jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval
Tickers AZN GSK MRNA PFE
Tags SNY GSK PFE
From MarketWatch
Was This $3 Billion Deal a Wise Move for Sanofi?
Tickers SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
3 Biotech Stocks to Avoid Like the Plague
Tickers AMRN IBB MNKD SAVA
Tags IBB AMRN Market News
From InvestorPlace
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
Tickers REGN SNY
Tags Benzinga REGN Health Care
From Benzinga
2 Bear Market Defying Stocks to Buy in May
Tickers AXSM SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
FDA advisers vote in favor of Pfizer’s maternal RSV vaccine
Tickers AZN GSK PFE SNY
Tags SPX AZN SNY
From MarketWatch
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags RHHVF Health Care Benzinga
From Benzinga
AI Meets Biotech: Transforming the Drug Development Process
Tickers AZN BAYRY RHHBY SNY
Tags Uncategorized SNY BAYRY
From InvestorPlace
Peering Into Sanofi's Recent Short Interest
Tickers SNY
Tags Market News BZI/SHORTHIST Short Sellers
From Benzinga
Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing
Tickers CI LLY NVO SNY
Tags Health Care LLY Legal
From Benzinga
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
Tickers AZN AZNCF GSK SNY
Tags General AZNCF Benzinga
From Benzinga
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
Tickers CI CVS LLY NVO
Tags NVO CVS CI
From MarketWatch
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
Tickers FOLD PLX SNY
Tags FDA PLX Biotech
From Benzinga
7 Blue-Chip Stocks to Buy in May 2023
Tickers AMGN FRC JPM LMT
Tags JPM SNY NYSE:LMT,NASDAQ:AMGN,NASDAQ:SNY,NYSE:VZ,NYSE:SHEL,NASDAQ:QCOM,NYSE:TSM,NYSE:FRC,NYSE:JPM
From InvestorPlace
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Tickers REGN SNY
Tags why it's moving General Benzinga
From Benzinga
7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Tickers ABBV INTC MSFT MXL
Tags SNY MXL MSFT
From InvestorPlace
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
Tickers ADDYY ALPMY BLMN BNTX
Tags CS Legal REVRQ
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
Tickers BNTX MRNA NVAX PFE
Tags Top Stories Benzinga MRNA
From Benzinga
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
Tickers SNY
Tags SNY Large Cap General
From Benzinga
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Tickers SNY
Tags Recent Press Releases SNY Market News
From Motley Fool
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
Tickers REGN SNY
Tags Earnings Biotech General
From Benzinga
Earnings Scheduled For April 27, 2023
Tickers OPRA ORC ORI OSK
Tags RWT ROG VC
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
Tickers AAL ABBV AMGN AMZN
Tags Small Cap AMGN Pre/Market Outlook
From Benzinga
Earnings Outlook For Sanofi
Tickers SNY
Tags Benzinga BZI/EP SNY
From Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Tickers BAYRY GSK HLN INTC
Tags News SNY Large Cap
From Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
Tickers GSK MRK SNY TAK
Tags Health Care SNY News
From Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Tickers EWTX IPHA PRVB SGEN
Tags SGEN Small Cap PRVB
From Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
Tickers AMGN AZN BIIB BLUE
Tags GILD LLY Penny Stocks
From Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
Tickers PRVB SNY TLSA
Tags Partner Content TLSA Tiziana Life Sciences
From Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
Tickers PRVB SNY
Tags Briefs PRVB Market News
From Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News